CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended		124 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,326,522)	$ (988,106)	$ (22,679,057)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization	6,155	6,102	286,622
Non-cash fair value of common stock issued for consulting		25,150	179,538
Share-based compensation related to employee stock options	128,972	134,525	3,440,369
Amortization of debt discount			19,292
Non-cash fair value of stock options issued to non-employees for consulting	2,873	112,292	1,383,588
Non-cash fair value of warrants issued to non-employees			134,420
Expenses paid by issuance of preferred and common stock			247,650
Loss on fixed asset dispositions			200,940
Non-cash interest expense on beneficial conversion			27,500
Gain on debt and accounts payable settlement			(1,622,752)
Loss on early extinguishment of debt			61,419
Net loss on sale of trading securities	183,598		1,001,963
Unrealized loss on trading securities	(141,739)		94,404
Loss on revaluation of derivative warrant liabilitiy	64,920		281,621
(Increase) decrease in:
Accounts receivable			50,000
Prepaid expenses and other	(17,571)	37,134	(70,530)
Increase (decrease) in:
Accounts payable	142,654	57,215	844,795
Accrued expenses	(82,615)	(56,511)	587,161
Net Cash Used by Operating Activities	(1,039,275)	(672,199)	(15,531,057)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of investments, net	416,554		2,222,604
Cash paid for intangible assets			(161,609)
Net cash received in acquisition			69
Cash paid for purchase of property and equipment	(5,321)	(1,029)	(423,649)
Net Cash Used by Investing Activities	411,233	(1,029)	1,637,415
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of notes - stockholders, net			1,730,000
Repayment of notes payable - stockholders			(55,000)
Proceeds from issuance of short-term convertible notes			608,165
Advances from stockholders			679,500
Proceeds from sale of common stock, net	203,055		9,208,199
Proceeds from sale of preferred stock, net			2,440,966
Net Cash Provided by Financing Activities	203,055		14,611,830
Net Increase (Decrease) in Cash and Cash Equivalents	(424,987)	(673,228)	718,188
Cash and Cash Equivalents, Beginning of Period	1,143,175
Cash and Cash Equivalents, End of Period	718,188	630,860	718,188
Supplemental Cash Flow Disclosures:
Interest expense paid in cash			5,297
Tax paid	956		2,618
Supplemental Non-Cash Disclosure:
Accrued expenses settled in preferred stock			57,196
Sale of preferred stock for marketable equity securities			3,495,384
Fair value of warrants issued to Series B holders			(2,224,778)
Fair value of warrants modified in connection with Series B financing	(114,923)		(228,608)
Fair value of warrants issued to Series B placement agents	(12,738)		(36,346)
Conversion of preferred stock to common stock			288
Notes payable - stockholder - settled in common stock			2,135,000
Accrued interest - stockholder - settled in common stock			188,569
Notes payable - stockholder - settled in preferred stock			275,000
Preferred Stock Dividend	(145,794)	(44,057)	(2,967,881)
Advances from stockholders settled in common stock			679,500
Accounts payable settled in common stock			471,472
Accounts payable settled in common stock options			30,500
Accrued expenses settled in common stock options			3,000
Decrease in accounts payable related to fixed asset disposition			133,314
Decrease in accounts payable related to settlement			1,622,752
Decrease in accrued expenses related to settlement			3,000
Increase in accounts receivable related to common stock issuance			50,000
Warrants issued with convertible notes payable			7,474
Conversion of Series A preferred shares to common stock	(1,373)		(1,373)
Conversion of Series B preferred shares and accrued dividends to common stock	$ (31)		$ (31)